LA JOLLA, Calif. -- EpicentRx, Inc., a clinical cancer immunotherapy company targeting both sides of the immune system to deliver cancer treatments with minimal toxicity, announced today that it opened a trial site at the Salt Lake City-based Utah Cancer Specialists for the Ph...